These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6734943)

  • 41. Time-dependent involvement of autonomic nervous system in hyperglycemia due to 2-deoxy-D-glucose.
    Yamamoto H; Nagai K; Nakagawa H
    Am J Physiol; 1988 Dec; 255(6 Pt 1):E928-33. PubMed ID: 2904768
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Naloxone attenuates recovery from insulin-induced hypoglycemia in normal man.
    Bright GM; Kaiser DL; Rogol AD; Clarke WL
    J Clin Endocrinol Metab; 1983 Jul; 57(1):213-6. PubMed ID: 6343416
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increments in glucose, glucagon and insulin after morphine in rats, and naloxone blocking of this effect.
    Johansen O; Tønnesen T; Jensen T; Jorde R; Burhol PG; Reikerås O
    Life Sci; 1992; 51(15):1237-42. PubMed ID: 1528092
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of intracellular glucopenia on pulsatile growth hormone secretion: mediation in part by somatostatin.
    Painson JC; Tannenbaum GS
    Endocrinology; 1985 Sep; 117(3):1132-8. PubMed ID: 2862015
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Effect of endogenous opioids on gastric functions in man].
    Suzuki J
    Hokkaido Igaku Zasshi; 1993 Nov; 68(6):836-48. PubMed ID: 8112709
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Opioid effects on plasma concentrations of luteinizing hormone and prolactin in the adult male rhesus monkey.
    Gilbeau PM; Almirez RG; Holaday JW; Smith CG
    J Clin Endocrinol Metab; 1985 Feb; 60(2):299-305. PubMed ID: 2981242
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Endogenous opioids and ventilatory responses to hypercapnia in normal humans.
    Weinberger SE; Steinbrook RA; Carr DB; von Gal ER; Fisher JE; Leith DE; Fencl V; Rosenblatt M
    J Appl Physiol (1985); 1985 May; 58(5):1415-20. PubMed ID: 3158633
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Involvement of cerebral neurotensin in hyperglycemic response caused by 2-deoxy-D-glucose in rats.
    Chun SJ; Niijima A; Shimizu K; Nagai K
    Neurosci Lett; 1995 Dec; 201(3):191-4. PubMed ID: 8786837
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Endocrine actions of opioids.
    Pfeiffer A; Herz A
    Horm Metab Res; 1984 Aug; 16(8):386-97. PubMed ID: 6088380
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Endorphins in septic shock: hemodynamic and endocrine effects of an opiate receptor antagonist and agonist.
    Gahhos FN; Chiu RC; Hinchey EJ; Richards GK
    Arch Surg; 1982 Aug; 117(8):1053-7. PubMed ID: 6285853
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of blood glucose level regulation in mouse opioid withdrawal models.
    Park SH; Sim YB; Kang YJ; Kim SM; Lee JK; Jung JS; Suh HW
    Neurosci Lett; 2010 Jun; 476(3):119-22. PubMed ID: 20226840
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Morphine and naloxone: effects on beta-endorphin immunoreactivity in canine plasma and secretions from rat pituitaries.
    Levin ER; Sharp B; Meyer NV; Carlson HE
    Endocrinology; 1981 Jul; 109(1):146-51. PubMed ID: 6263581
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Melatonin suppresses hyperglycemia caused by intracerebroventricular injection of 2-deoxy-D-glucose in rats.
    Shima T; Chun SJ; Niijima A; Bizot-Espiard JG; Guardiola-Lemaitre B; Hosokawa M; Nagai K
    Neurosci Lett; 1997 Apr; 226(2):119-22. PubMed ID: 9159504
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The essentiality of insulin and the role of glucagon in regulating glucose utilization and production during strenuous exercise in dogs.
    Vranic M; Kawamori R; Pek S; Kovacevic N; Wrenshall GA
    J Clin Invest; 1976 Feb; 57(2):245-55. PubMed ID: 1254723
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Somatostatin: central nervous system actions on glucoregulation.
    Brown M; Rivier J; Vale W
    Endocrinology; 1979 Jun; 104(6):1709-15. PubMed ID: 446391
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Little or no induction of hyperglycemia by 2-deoxy-D-glucose in hereditary blind microphthalmic rats.
    Nagai K; Sekitani M; Otani K; Nakagawa H
    Life Sci; 1988; 43(20):1575-82. PubMed ID: 3057302
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Endogenous opiates do not influence glucose and lipid metabolism in rat adipocytes.
    Hauner H; Glatting G; Ditschuneit HH; Pfeiffer EF
    Exp Clin Endocrinol; 1988 Aug; 91(3):350-4. PubMed ID: 3075186
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The role of glucagon deficiency in the Houssay phenomenon of dogs.
    Nakabayashi H; Dobbs RE; Unger RH
    J Clin Invest; 1978 May; 61(5):1355-62. PubMed ID: 659597
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Beta-endorphin and islet hormone release in type-2 diabetes mellitus the effects of normoglycemia, enkephalin, naloxone and somatostatin.
    Giugliano D; Cozzolino D; Salvatore T; Ceriello A; Giunta R; Torella R; D'Onofrio F
    Diabete Metab; 1987; 13(6):618-24. PubMed ID: 2896134
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Suppression of renin release by antagonism of endogenous opiates in the dog.
    Szilagyi JE; Chelly J; Doursout MF
    Am J Physiol; 1986 Apr; 250(4 Pt 2):R633-7. PubMed ID: 3515972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.